Self-Assembling Protein Nanoparticles: implications for HIV-1 vaccine development

被引：12
作者：
Karch, Christopher P. [1 ,2 ]
Matyas, Gary R. [1 ]
Burkhard, Peter [3 ]
Beck, Zoltan [1 ,2 ]
机构：
[1] Walter Reed Army Inst Res, US Mil HIV Res Program, Lab Adjuvant & Antigen Res, 503 Robert Grant Ave, Silver Spring, MD 20910 USA
[2] Henry M Jackson Fdn Adv Mil Med, 6720A Rockledge Dr, Bethesda, MD 20817 USA
[3] Alpha O Peptides, Lorracherstr 50, CH-4125 Riehen, Switzerland
来源：
NANOMEDICINE | 2018年 / 13卷 / 17期
关键词：
antigen density; conformational antibody; HIV-1; nanoparticle; SAPN; trimeric epitope; vaccine; PROTECTION; EFFICACY; DESIGN;
D O I：
10.2217/nnm-2018-0222
中图分类号：
Q81 [生物工程学（生物技术）]; Q93 [微生物学];
学科分类号：
071005 ; 0836 ; 090102 ; 100705 ;
摘要：
[No abstract available]
引用
收藏
页码：2121 / 2126
页数：6
相关论文
共 50 条
  • [1] Malaria vaccine based on self-assembling protein nanoparticles
    Burkhard, Peter
    Lanar, David E.
    EXPERT REVIEW OF VACCINES, 2015, 14 (12) : 1525 - 1527
  • [2] Impact of the expression system on the immune responses to self-assembling protein nanoparticles (SAPNs) displaying HIV-1 V1V2 loop
    Karch, Christopher P.
    Paquin-Proulx, Dominic
    Eller, Michael A.
    Matyas, Gary R.
    Burkhard, Peter
    Beck, Zoltan
    NANOMEDICINE-NANOTECHNOLOGY BIOLOGY AND MEDICINE, 2020, 29 (29)
  • [3] The biodistribution of self-assembling protein nanoparticles shows they are promising vaccine platforms
    Yang, Yongkun
    Neef, Tobias
    Mittelholzer, Christian
    Garayoa, Elisa Garcia
    Blauenstein, Peter
    Schibli, Roger
    Aebi, Ueli
    Burkhard, Peter
    JOURNAL OF NANOBIOTECHNOLOGY, 2013, 11
  • [4] Design and characterization of a self-assembling protein nanoparticle displaying HIV-1 Env V1V2 loop in a native-like trimeric conformation as vaccine antigen
    Karch, Christopher P.
    Bai, Hongjun
    Torres, Oscar B.
    Tucker, Courtney A.
    Michael, Nelson L.
    Matyas, Gary R.
    Rolland, Morgane
    Burkhard, Peter
    Beck, Zoltan
    NANOMEDICINE-NANOTECHNOLOGY BIOLOGY AND MEDICINE, 2019, 16 : 206 - 216
  • [5] Presenting native-like trimeric HIV-1 antigens with self-assembling nanoparticles
    He, Linling
    de Val, Natalia
    Morris, Charles D.
    Vora, Nemil
    Thinnes, Therese C.
    Kong, Leopold
    Azadnia, Parisa
    Sok, Devin
    Zhou, Bin
    Burton, Dennis R.
    Wilson, Ian A.
    Nemazee, David
    Ward, Andrew B.
    Zhu, Jiang
    NATURE COMMUNICATIONS, 2016, 7
  • [6] The biodistribution of self-assembling protein nanoparticles shows they are promising vaccine platforms
    Yongkun Yang
    Tobias Neef
    Christian Mittelholzer
    Elisa Garcia Garayoa
    Peter Bläuenstein
    Roger Schibli
    Ueli Aebi
    Peter Burkhard
    Journal of Nanobiotechnology, 11
  • [7] The diversity of HIV-1 fights against vaccine efficacy: how self-assembling protein nanoparticle technology may fight back
    Karch, Christopher P.
    Burkhard, Peter
    Matyas, Gary R.
    Beck, Zoltan
    NANOMEDICINE, 2021, 16 (08) : 673 - 680
  • [8] A self-assembling nanoparticle: Implications for the development of thermostable vaccine candidates
    Liu, Ze-Hui
    Xu, Hui-Ling
    Han, Guang-Wei
    Tao, Li-Na
    Lu, Ying
    Zheng, Su-Ya
    Fang, Wei-Huan
    He, Fang
    INTERNATIONAL JOURNAL OF BIOLOGICAL MACROMOLECULES, 2021, 183 : 2162 - 2173
  • [9] Development of a self-assembling protein nanoparticle vaccine targeting Plasmodium falciparum Circumsporozoite Protein delivered in three Army Liposome Formulation adjuvants
    Seth, Labdhi
    Ferlez, Karen M. Bingham
    Kaba, Stephen A.
    Musser, Derek M.
    Emadi, Sharareh
    Matyas, Gary R.
    Beck, Zoltan
    Alving, Carl R.
    Burkhard, Peter
    Lanar, David E.
    VACCINE, 2017, 35 (41) : 5448 - 5454
  • [10] Self-assembling protein nanoparticles with built-in flagellin domains increases protective efficacy of a Plasmodium falciparum based vaccine
    Kaba, Stephen A.
    Karch, Christopher P.
    Seth, Labdhi
    Ferlez, Karen M. B.
    Storme, Casey K.
    Pesavento, Danielle M.
    Laughlin, Paige Y.
    Bergmann-Leitner, Elke S.
    Burkhard, Peter
    Lanar, David E.
    VACCINE, 2018, 36 (06) : 906 - 914
12345